Cargando…
Lung cancer biomarkers: State of the art
Lung cancer is one of the deadliest cancers worldwide, with the highest incidence and mortality amongst all cancers. While the prognosis of lung cancer is generally grim, with 5-year survival rates of only 15%, there is hope, and evidence, that early detection of lung cancer can reduce mortality. To...
Autores principales: | Subramaniam, Sangeetha, Thakur, Ram Krishna, Yadav, Vinod Kumar, Nanda, Ranjan, Chowdhury, Shantanu, Agrawal, Anurag |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622361/ https://www.ncbi.nlm.nih.gov/pubmed/23599685 http://dx.doi.org/10.4103/1477-3163.107958 |
Ejemplares similares
-
Impulse oscillometry: The state-of-art for lung function testing
por: Desiraju, Koundinya, et al.
Publicado: (2016) -
Functional genomics of lung cancer progression reveals mechanism of metastasis suppressor function
por: Thakur, Ram Krishna, et al.
Publicado: (2014) -
Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells
por: Kar, Anirban, et al.
Publicado: (2012) -
Engineered reversal of drug resistance in cancer cells—metastases suppressor factors as change agents
por: Yadav, Vinod Kumar, et al.
Publicado: (2014) -
Biomarkers and Lung Cancer Early Detection: State of the Art
por: Dama, Elisa, et al.
Publicado: (2021)